Drug intelligence / Profile preview

CC8

Development stage
Preclinical
Modality
Recombinant Proteins and Enzymes, Peptides
01

Overview

CC8 is a heterodimeric disintegrin isolated from the venom of the North African horned viper, *Cerastes cerastes*. It belongs to a class of small, cysteine-rich proteins that are potent inhibitors of integrin-mediated cell adhesion. In preclinical research, CC8 has demonstrated significant anticancer activity against human glioblastoma (GBM) cells by triggering apoptosis and restraining tumor cell dissemination. Its mechanism of action involves the competitive antagonism of integrin receptors on the cell surface, which disrupts essential interactions between the tumor cells and the extracellular matrix. This disruption leads to the inhibition of cell migration and the induction of programmed cell death, making CC8 a potential therapeutic lead for the treatment of aggressive and invasive brain tumors.

02

Targets

GPIIb/IIIa (Integrin alpha-IIb/beta-3)ITGA5:ITGB1 (Integrin α5β1)αVβ3 (Integrin αVβ3)

Beyond the preview

Go deeper on CC8.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CC8.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call